Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin plus inositol versus inositol alone before IVF/ICSI in women with polycystic ovarian syndrome
IRCT20240128060827N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of sitagliptin and bCalm in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: Embryo quality and Oocyte quality. Started Apr 2024; status: completed.
02
Drugs
sitagliptinbCalm
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on IRCT20240128060827N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240128060827N1.